BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15459215)

  • 21. A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia.
    ElHarouni D; Yassin D; Ali N; Gohar S; Zaky I; Adwan H; Sidhom I
    Front Oncol; 2018; 8():541. PubMed ID: 30533396
    [No Abstract]   [Full Text] [Related]  

  • 22. Whole-joint magnetic resonance imaging to assess osteonecrosis in pediatric patients with acute lymphoblastic lymphoma.
    Inaba H; Varechtchouk O; Neel MD; Ehrhardt MJ; Metzger ML; Karol SE; Ness KK; Ribeiro RC; Pui CH; Relling MV; Sandlund JT; Kaste SC
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28336. PubMed ID: 32472969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone pain at leukemia diagnosis and other risk factors for symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
    Barzilai-Birenboim S; Yacobovich J; Zalcberg Y; Arad-Cohen N; Avrahami G; Gilad G; Litichever N; Izraeli S; Elitzur S
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29033. PubMed ID: 33788395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ALL and osteonecrosis.
    Gaynon PS
    Blood; 2015 Oct; 126(15):1734-5. PubMed ID: 26450951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Mattano LA; Sather HN; Trigg ME; Nachman JB
    J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients.
    Gagné V; Aubry-Morin A; Plesa M; Abaji R; Petrykey K; St-Onge P; Beaulieu P; Laverdière C; Alos N; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
    Pharmacogenomics; 2019 Nov; 20(17):1189-1197. PubMed ID: 31686588
    [No Abstract]   [Full Text] [Related]  

  • 27. Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival.
    Ongaro A; De Mattei M; Della Porta MG; Rigolin G; Ambrosio C; Di Raimondo F; Pellati A; Masieri FF; Caruso A; Catozzi L; Gemmati D
    Haematologica; 2009 Oct; 94(10):1391-8. PubMed ID: 19648163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ancestry and pharmacogenetics of antileukemic drug toxicity.
    Kishi S; Cheng C; French D; Pei D; Das S; Cook EH; Hijiya N; Rizzari C; Rosner GL; Frudakis T; Pui CH; Evans WE; Relling MV
    Blood; 2007 May; 109(10):4151-7. PubMed ID: 17264302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. British OsteoNEcrosis Study (BONES) protocol: a prospective cohort study to examine the natural history of osteonecrosis in older children, teenagers and young adults with acute lymphoblastic leukaemia and lymphoblastic lymphoma.
    Amin N; Kinsey S; Feltbower R; Kraft J; Whitehead E; Velangi M; James B
    BMJ Open; 2019 May; 9(5):e027204. PubMed ID: 31122988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence, risk factors, and treatment outcome of symptomatic osteonecrosis in Taiwanese children with acute lymphoblastic leukemia: a retrospective cohort study of 245 patients in a single institution.
    Chen SH; Chang TY; Jaing TH; Lee MS; Wang CJ; Hung IJ; Yang CP
    Int J Hematol; 2015 Jul; 102(1):41-7. PubMed ID: 25840770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Toft N; Birgens H; Abrahamsson J; Griškevičius L; Hallböök H; Heyman M; Klausen TW; Jónsson ÓG; Palk K; Pruunsild K; Quist-Paulsen P; Vaitkeviciene G; Vettenranta K; Asberg A; Helt LR; Frandsen T; Schmiegelow K
    Eur J Haematol; 2016 Feb; 96(2):160-9. PubMed ID: 25867866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of hip and knee osteonecrosis and their associations with bone mineral density in children with acute lymphoblastic leukaemia.
    Inaba H; Cao X; Chang JY; Karol SE; Panetta JC; Ness KK; Cheng C; Pui CH; Relling MV; Kaste SC
    Br J Haematol; 2020 May; 189(4):e177-e181. PubMed ID: 32207157
    [No Abstract]   [Full Text] [Related]  

  • 33. Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL).
    Padhye B; Dalla-Pozza L; Little D; Munns C
    Cancer Med; 2016 May; 5(5):960-7. PubMed ID: 26792372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteonecrosis in children treated for acute lymphoblastic leukemia: a magnetic resonance imaging study after treatment.
    Düzovali O
    Med Pediatr Oncol; 1999 Feb; 32(2):154-5. PubMed ID: 9950209
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemia.
    Plesa M; Gagné V; Glisovic S; Younan M; Sharif-Askari B; Laverdière C; Alos N; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
    Pharmacogenomics J; 2019 Feb; 19(1):33-41. PubMed ID: 29282361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia.
    Kishi S; Yang W; Boureau B; Morand S; Das S; Chen P; Cook EH; Rosner GL; Schuetz E; Pui CH; Relling MV
    Blood; 2004 Jan; 103(1):67-72. PubMed ID: 12969965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylenetetrahydrofolate reductase gene polymorphism and glucocorticoid intake in children with ALL and aseptic osteonecrosis.
    Bernbeck B; Mauz-Körholz C; Zotz RB; Göbel U
    Klin Padiatr; 2003; 215(6):327-31. PubMed ID: 14677097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia.
    Badhiwala JH; Nayiager T; Athale UH
    Pediatr Blood Cancer; 2015 Oct; 62(10):1851-4. PubMed ID: 25931304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma.
    Ribeiro RC; Fletcher BD; Kennedy W; Harrison PL; Neel MD; Kaste SC; Sandlund JT; Rubnitz JE; Razzouk BI; Relling MV; Pui CH
    Leukemia; 2001 Jun; 15(6):891-7. PubMed ID: 11417473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
    den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
    Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.